193 related articles for article (PubMed ID: 15812267)
1. An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels.
Ng CH; Chong SA; Lambert T; Fan A; Hackett LP; Mahendran R; Subramaniam M; Schweitzer I
Int Clin Psychopharmacol; 2005 May; 20(3):163-8. PubMed ID: 15812267
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with clozapine in Woodbridge Hospital.
Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
[TBL] [Abstract][Full Text] [Related]
6. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic resolution among Chinese patients with schizophrenia and associated factors.
Li CT; Su TP; Chou YH; Lee YC; Liu ME; Ku HL; Shan IK; Bai YM
J Formos Med Assoc; 2010 May; 109(5):378-88. PubMed ID: 20497871
[TBL] [Abstract][Full Text] [Related]
8. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
9. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
[TBL] [Abstract][Full Text] [Related]
11. Metabolic differences between Asian and Caucasian patients on clozapine treatment.
Subramaniam M; Ng C; Chong SA; Mahendran R; Lambert T; Pek E; Huak CY
Hum Psychopharmacol; 2007 Jun; 22(4):217-22. PubMed ID: 17431927
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
[TBL] [Abstract][Full Text] [Related]
13. Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.
Kim Y; Kim BN; Cho SC; Kim JW; Shin MS
Hum Psychopharmacol; 2008 Dec; 23(8):715-22. PubMed ID: 18814190
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
17. Clozapine dosages and plasma drug concentrations.
Chang WH; Lin SK; Lane HY; Hu WH; Jann MW; Lin HN
J Formos Med Assoc; 1997 Aug; 96(8):599-605. PubMed ID: 9290269
[TBL] [Abstract][Full Text] [Related]
18. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
19. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
20. Contrasting clozapine prescribing patterns in the east and west?
Chong SA; Remington GJ; Lee N; Mahendran R
Ann Acad Med Singap; 2000 Jan; 29(1):75-8. PubMed ID: 10748970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
